scholarly journals An epididymis-specific carboxyl esterase CES5A is required for sperm capacitation and male fertility in the rat

2015 ◽  
Vol 17 (2) ◽  
pp. 292 ◽  
Author(s):  
Yu-Chuan Zhou ◽  
Yong-Lian Zhang ◽  
Yan-Fei Ru ◽  
Hai-Min Xue ◽  
Zi-Mei Ni ◽  
...  
2021 ◽  
Author(s):  
Sequoyah Reynoso ◽  
Vanessa Castillo ◽  
Gajanan Dattatray Katkar ◽  
Inmaculada Lopez-Sanchez ◽  
Sahar Taheri ◽  
...  

For a sperm to successfully fertilize an egg, it must first undergo capacitation in the female reproductive tract, and later undergo acrosomal reaction (AR) upon encountering an egg surrounded by its vestment. How premature AR is avoided despite rapid surges in signaling cascades during capacitation remains unknown. Using a combination of KO mice and cell-penetrating peptides, we show that GIV (CCDC88A), a guanine nucleotide-exchange modulator (GEM) for trimeric GTPases, is highly expressed in spermatocytes and is required for male fertility. GIV is rapidly phosphoregulated on key tyrosine and serine residues in human and murine spermatozoa. These phosphomodifications enable GIV-GEM to orchestrate two distinct compartmentalized signaling programs in the sperm tail and head; in the tail, GIV enhances PI3K→Akt signals, sperm motility and survival, whereas in the head it inhibits cAMP surge and premature AR. Furthermore, GIV transcripts are downregulated in the testis and semen of infertile men. These findings exemplify the spatiotemporally segregated signaling programs that support sperm capacitation and shed light on a hitherto unforeseen cause of infertility in men.


PLoS ONE ◽  
2008 ◽  
Vol 3 (12) ◽  
pp. e4106 ◽  
Author(s):  
Yuchuan Zhou ◽  
Min Zheng ◽  
Qixian Shi ◽  
Li Zhang ◽  
Wei Zhen ◽  
...  

2020 ◽  
Vol 380 (2) ◽  
pp. 237-262 ◽  
Author(s):  
Michal Zigo ◽  
Pavla Maňásková-Postlerová ◽  
Dalen Zuidema ◽  
Karl Kerns ◽  
Věra Jonáková ◽  
...  

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Sequoyah Reynoso ◽  
Vanessa Castillo ◽  
Gajanan Dattatray Katkar ◽  
Inmaculada Lopez-Sanchez ◽  
Sahar Taheri ◽  
...  

For a sperm to successfully fertilize an egg, it must first undergo capacitation in the female reproductive tract and later undergo acrosomal reaction (AR) upon encountering an egg surrounded by its vestment. How premature AR is avoided despite rapid surges in signaling cascades during capacitation remains unknown. Using a combination of conditional knockout (cKO) mice and cell-penetrating peptides, we show that GIV (CCDC88A), a guanine nucleotide-exchange modulator (GEM) for trimeric GTPases, is highly expressed in spermatocytes and is required for male fertility. GIV is rapidly phosphoregulated on key tyrosine and serine residues in human and murine spermatozoa. These phosphomodifications enable GIV-GEM to orchestrate two distinct compartmentalized signaling programs in the sperm tail and head; in the tail, GIV enhances PI3K→Akt signals, sperm motility and survival, whereas in the head it inhibits cAMP surge and premature AR. Furthermore, GIV transcripts are downregulated in the testis and semen of infertile men. These findings exemplify the spatiotemporally segregated signaling programs that support sperm capacitation and shed light on a hitherto unforeseen cause of infertility in men.


2012 ◽  
Vol 153 (45) ◽  
pp. 1787-1792 ◽  
Author(s):  
Mária Horváth ◽  
Endre Czeizel

Introduction: There is a decline in male fertility thus new treatments are needed. Aims: To test the efficacy of a new dietary supplement developed in the USA and registered as a curing drug in Hungary (OGYI). Methods: In a clinical trial 100 men with low sperm quality (spermium count 5–20 M/ml, good motility 10–40%, and adverse shape 30–50%) were examined. Results: Sperm parameters were measured before and after a 3-month treatment and after another 3-month without treatment. This dietary supplement statistically and clinically significantly improved sperm count and motility. In 74 cases this dietary supplement demonstrated a beneficial effect on sperm quality (more than 10% increase in sperm count, or quality of motility, or shape); in 16 cases the improvement exceeded 30%. No adverse effect could be accounted for this treatment. Conclusions: This new dietary supplement may contribute to the treatment of male infertility. Orv. Hetil., 2012, 153, 1787–1792.


Sign in / Sign up

Export Citation Format

Share Document